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Abstract—This paper presents the Derivatives Combination
Predictor (DCP), a novel model fusion algorithm for making
long-term glucose predictions for diabetic people. First, using
the history of glucose predictions made by several models, the
future glucose variation at a given horizon is predicted. Then,
by accumulating the past predicted variations starting from a
known glucose value, the fused glucose prediction is computed.
A new loss function is introduced to make the DCP model learn
to react faster to changes in glucose variations.
The algorithm has been tested on 10 in-silico type-1 diabetic
children from the T1DMS software. Three initial predictors have
been used: a Gaussian process regressor, a feed-forward neural
network and an extreme learning machine model. The DCP and
two other fusion algorithms have been evaluated at a prediction
horizon of 120 minutes with the root-mean-squared error of
the prediction, the root-mean-squared error of the predicted
variation, and the continuous glucose-error grid analysis.
By making a successful trade-off between prediction accuracy
and predicted-variation accuracy, the DCP, alongside with its
specifically designed loss function, improves the clinical accept-
ability of the predictions, and therefore the safety of the model
for diabetic people.
Index Terms—Glucose Prediction, Model Fusion, Clinical Ac-
ceptability, Artificial Neural Network
I. INTRODUCTION
Diabetes, being the seventh leading cause of death in 2016,
is one of the major diseases of the XXI century [1]. In
order to avoid short-term (e.g., exhaustion, coma) or long-
term (e.g., blindness, cardiovascular diseases) complications,
diabetic people must maintain their blood glucose within
acceptable ranges (i.e., between hypoglycemia and hyper-
glycemia). However, this task is far from easy given the high
variety of factors influencing the variations of blood glucose
(e.g., food intake, medications, physical activity, emotions).
Innovations that aim at helping diabetic people in their
daily lives follow several leads. First, monitoring devices such
as continuous glucose monitors (e.g., FreeStyle Libre [2]) or
medical coaching applications for diabetes (e.g., mySugr [3])
provide diabetic people with useful information such as current
and past glucose values or calories intake history. Moreover,
artificial pancreas start being commercialized and have already
shown their effectiveness in managing the blood glucose
of diabetic patients [4]. Finally, nowadays, a lot of efforts
have been focused towards the building of glucose predictive
models [5]. From the patient’s past glucose, carbohydrate
(CHO) intakes, and insulin infusions, those models try to
predict future glucose values.
In the past few years, a lot of different glucose predictive
model architectures have been tried-out. Among them, Sun
et al. proposed a generic predictive model using Long Short-
Term Memory (LSTM) and bidirectional LSTM neural net-
works to predict glucose at prediction horizons (PH) up to
60 minutes [6]. De Paula et al. studied the use of Gaussian
Processes (GP) to predict future glucose values in an auto-
mated glucose controller based on reinforcement learning [7].
Besides, in their work, Georga et al. analyzed different types of
Extreme Learning Machine (ELM) networks for online short-
term glucose prediction [8]. Finally, Ben Ali et al. proposed
a tuning methodology for the architecture of Feed-Forward
Neural Networks (FFNN) that aims at improving the glucose
predictions of diabetic patients up to 60 minutes ahead [9].
Nonetheless, to this day, no algorithm is standing out
from the others, with each of them having its own strengths
and weaknesses [10]. Several studies tried to make use of
those specificities by combining the different predictions into
a single one. Wang et al. proposed the adaptive-weighted-
average framework that combines glucose predictive models
by weighing them based on their past errors [11]. Daskalaki et
al. built a hypoglycemia/hyperglycemia events warning system
by combining autoregressive and recurrent neural networks
models [12], [13]. More recently, Jankovic et al. studied a
multi-step fusion methodology using ELM models for long-
term glucose prediction [14]. Finaly, Yu et al. proposed an
adapative-filters-based fusion mechanism for short-term glu-
cose prediction [15].
However, this particular question of long-term predictions
remains an open problem. Due to the difficulty of the task,
the models often output predictions that are inconsistent over
time with a lot of high amplitude oscillations. This inconsis-
tency directly impacts the clinical acceptability, measured by
the Continuous Glucose-Error Grid Analysis (CG-EGA). To
address this issue, we propose a novel model fusion algorithm,
the Derivatives Combination Predictor (DCP), that bases its
predictions on the prediction of glucose variations.
The paper is organized as follows. First, we introduce our
algorithm. Then, we go through the different details about
the experiments we have conducted during the study. Finally,
before concluding, we provide the reader with an analysis of
the results.
II. DERIVATIVES COMBINATION PREDICTOR
A. Presentation of the Model
The goal of the DCP is to make the glucose predictions
consistent with each other. In particular, it tries to make the
difference between two consecutive predictions as close to the
true glucose variation as possible. To do so, the DCP com-
bines the predictions made by different predictors at a given
prediction horizon (PH) into a single prediction following a
two-step process (see Figure 1).
First, at time t, the a model we call dModel predicts the
glucose variation at time t+PH , ˆ˙yt+PH , from the past history
of glucose predictions, Yˆ Baset+PH , made by the initial predictors
Base.
Then, starting from the most recent glucose value known
by the predictor (i.e., the glucose value at time t, when the
prediction is made), the fused glucose prediction, yˆDCPt+PH , is
computed by accumulating the last PH predicted derivatives
(see Equation 1).
yˆDCPt+PH = yt +
PH∑
i=1
ˆ˙yt+i (1)
Example. We want to fuse two predictors, A and B, that
forecast glucose values 120 minutes in the future (PH of
120 minutes). At every time-step t, we forecast the glucose
derivative (rate of change) 120 minutes in the future by
giving the history of glucose predictions made by A and B
to the dModel. With a history of 5, we give the dModel the
predictions made by A and B at t+120, t+119, ..., t+116. The
way the glucose variations are predicted depends on the nature
of the dModel which can be any regression model (e.g., linear
regressor or neural network). Once the glucose derivatives are
predicted up to t+120, we can compute the glucose prediction
at t+ 120 by using the last 120 glucose derivative predictions
and the current glucose value using Equation 1.
B. Learning of the dModel
While any supervised regression model can fit into the
dModel, we chose to use a FFNN for its flexibility and its
ability to model complex non-linear functions. To enhance
the accuracy of the glucose predictions computed from the
predicted derivatives, we introduce a new loss function to be
used inside the FFNN-based dModel : the Derivatives-Biased
Mean-Squared Error (MSEDB).
The MSEDB (see Equation 2) is quite similar to the MSE
loss function. For every sample i, with a small enough value
of σ, the squared error will be scaled by 1± γ depending on
the value of ˆ˙yi/y˙i. If ˆ˙yi/y˙i > 1, meaning either ˆ˙yi > y˙i > 0
or ˆ˙yi < y˙i < 0, then the loss attributed to this sample is scaled
down; if not, it is scaled up.
MSEDB(y˙, ˆ˙y) =
1
n
n∑
i=1
(1 + γ · tanh(1−
ˆ˙yi/y˙i
σ
))(y˙i − ˆ˙yi)2
(2)
Intuitively, using this loss function during training means
that we encourage the model to predict derivatives with the
same sign as and higher absolute values than the true values.
In practice, this makes our model react faster to changes in
variations of glucose, and, therefore, make the predictions
more accurate.
III. EXPERIMENTAL RESULTS
A. Experimental Data
In this study, we used the 10 in-silico children population
from the UVA/Padova Type 1 Diabetes Metabolic Simulator
(T1DMS) [16]. T1DMS has been approved by the Food and
Drug Administration in the United States as a substitute to
clinical testing and is, therefore, extensively used in the glu-
cose prediction literature [5]. Compared to data coming from
real patients, which are sensitive and oftentimes impossible to
be shared, simulated data can be reproduced. Therefore, using
the simulator makes our results reproducible and available for
comparison.
The simulation lasted 28 days and outputted three different
time-series sampled every minute: glucose value, insulin in-
fusion and carbohydrate (CHO) intake over time. To account
for the diversity of real-life situations, the subjects have been
put under the following daily open-loop scenario:
1) Meals: Every day is made of 3 meals, with each meal’s
timing and CHO amount being sampled from Gaussian dis-
tributions. The timing Gaussian distributions have a variance
of 0.5 and a mean of 7h, 13h and 20h respectively. The CHO
amount Gaussian distributions have a variance of 0.5 and a
mean of 40g, 85g and 60g respectively. Every meal lasts 15
minutes.
2) Insulin Boluses: At the start of every meal an insulin
bolus is taken. The value of the bolus is sampled uniformly
between 0.7 and 1.3 times the optimal insulin bolus. The
optimal insulin bolus is computed by the simulator from the
child’s personal carbohydrate-to-insulin ratio.
3) Basal Insulin: The basal insulin, computed by the sim-
ulator, is constant and optimal for every child.
B. Base Predictors
The predictions of three popular (in the context of glucose
prediction) predictors have been used as the input to the DCP:
a Feed-forward Neural Network (FFNN), a Gaussian Process
regressor (GP), and an Extreme Learning Machine network
(ELM) [5], [7]–[10], [14]. All the models have been optimized
through the tuning of their hyperparameters.
1) Data Preprocessing: Keeping their sequential nature
intact, the time-series outputted by the simulator have been
grouped by days and then split into train and test subsets. The
splitting has been done according to a 4 fold cross-validation
used during the training and testing of the models. For each
Yˆ Base(t−PH)+PH dModel ˆ˙y(t−PH)+PH
... ... ...
Yˆ Baset+PH dModel
ˆ˙yt+PH
yt
∑
yˆDCPt+PH
Fig. 1: DCP data flow, from the initial glucose predictions made by the Base predictors we want to fuse to the prediction of the glucose
derivatives by the dModel and the computation of the fused glucose predictions.
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Fig. 2: Surface plots of the per sample MSE (1) and MSEDB with γ = 0.65 and σ = 10−5 (2) loss functions.
testing fold, a third of the training set constitutes the evaluation
set, used to tune the models. After data normalization (zero-
mean and unit-variance), the time-series are fed to the models
as histories of the past 60 values (1 hour-long history).
2) GP: The GP model has been implemented with a dot-
product kernel [10]. Whereas the kernel coefficient and the
inhomogeneity have been set to 0.5 and 0.01 respectively,
the noise-controlling hyperparameter has been grid-searched
inside the [10−2, 101] range.
3) ELM: Given the inherent simplicity of ELM models
in general (no training and close to no tuning are needed),
we optimized the number of neurons inside its single hidden
layer within the [1, 20160] range (20160 being the number of
training samples) [17]. To reduce the overfitting of the model
to the training set, we added a L2 penalty (101) to the weights
of the neurons.
4) FFNN: The FFNN model is made of 4 hidden layers of
respectively 128, 64, 32, and 16 neurons. We used the scaled
exponential linear unit (SELU) activation function [18]. The
model is trained by the Adam optimizer with the mean-squared
error (MSE) loss function, mini-batches of size 1500, initial
learning rate and decay of 10−3 and 10−4 respectively. To fight
the overfitting of the model, we used several regularization
methods, namely a L2 penalty of 10−4 and early stopping.
C. DCP Implementation
The FFNN-based dModel is made of 3 hidden layers
of respectively 256, 128, and 64 neurons (ReLU activation
function). The network takes as input the history of the 10
past predictions from the 3 base predictors, making-up to 30
inputs.
For every train/test split, the network has been trained
for 500 epochs with mini-batches of size 2500. To avoid
the overfitting of the network to the training set, we used
batch normalization layers (applied between the outputs of
the neurons and the activation functions) and dropout (rate of
0.5). Furthermore, early stopping has been applied to the root-
mean-squared error of the glucose predictions (computed with
Equation 1) made on the evaluation set (1/6 of the training set,
not used during training). Finally, the γ and σ coefficients of
the MSEDB loss function has been optimized through grid-
search, ending with a value of 0.65 and 10−5 respectively.
D. Fusion Models for Comparison
In order to evaluate the performance of the DCP, we
implemented two other fusion algorithms: a model we call
the Artificial neural network Combination Predictor (ACP) and
the Adaptive-Weighed-Average (AWA) fusion algorithm from
Wang et al. [11].
1) ACP: The ACP model is a FFNN with the exact same
architecture as the FFNN-based dModel. However, instead of
predicting the glucose derivatives, it directly predicts the future
glucose values. Therefore, the MSEDB loss function cannot be
used since it is tailored to the dModel. The traditional MSE
loss function has been used in its stead. The purpose of this
model is to compare the DCP, a fusion model that predicts
the future glucose values through the prediction of the future
variations, to a model that directly predicts the future glucose
values.
2) AWA: The idea behind the AWA model is that every base
predictor is assigned a weight based on its past recent errors.
The weights are dynamically changed with the knowledge of
new prediction errors. To strenghen the impact of the most
recent errors on the weights, a forgetting factor is used [11].
It has been optimized through grid search and ended up with
a value of 0.99.
E. Evaluation Metrics
In this study, we use three complementary metrics to evalu-
ate the models: the Root-Mean-Squared Error of the prediction
(RMSE), the Root-Mean-Squared Error of predicted variations
(dRMSE), and the Continuous Glucose-Error Grid Analysis
(CG-EGA). Whereas the RMSE and the dRMSE provide with
the accuracy of the predictions, the CG-EGA measures the
clinical acceptability of the models.
1) RMSE: The RMSE (see Equation 3, with y and yˆ
being, respectively, the true and predicted glucose values) is a
standard metric to evaluate regression models and in particular
glucose predictive models. It provides a measure of the average
accuracy of the glucose predictions.
RMSE(y, yˆ) =
√√√√ 1
n
n∑
i=1
(yi − yˆi)2 (3)
2) dRMSE: The dRMSE is simply the RMSE applied to the
derivatives of the glucose predictions instead of the glucose
predictions themselves. It gives a measure of the accuracy of
the variations of the predictions when compared to the true
variations.
dRMSE(y, yˆ) =
√√√√ 1
n− 1
n−1∑
i=1
(∆yi −∆yˆi)2 (4)
3) CG-EGA: The CG-EGA is the most used metric in
evaluating glucose predictive models as it measures the clinical
acceptability of the predictions [5]. In particular, it assesses,
for every prediction, depending on the glycemia region (hy-
poglycemia, euglycemia1, hyperglycemia), the dangerousness
of making such a prediction. This is very useful in the context
of diabetes management since prediction errors can threaten
the life of the patient.
1The euglycemia region is the region between hypoglycemia and hyper-
glycemia (between 70 mg/dL and 180 mg/dL).
Technically, the CG-EGA is made of two evaluation grids:
the point-error grid analysis (P-EGA) and the rate-error grid
analysis (R-EGA). While the P-EGA determines the clinical
acceptability of the predictions themselves, the R-EGA focuses
on the rates of change (the difference between two consecutive
glucose predictions). The clinical acceptability is described
by grades, from A to E, for both grids (Figure 4 provides
the reader with a graphical example of the two grids). The
overall clinical acceptability of the prediction is assessed by
combining the two grids and classifying the prediction as
either an accurate prediction (AP), a benign error (BE) or an
erroneous prediction (EP). If a prediction and its associated
derivative are both classified into the A or B categories, the
prediction is then an AP.
4) Complementarity of the Chosen Metrics: Whereas the
RMSE and the P-EGA evaluate the accuracy of glucose
predictions, the dRMSE and the R-EGA focus on the predicted
glucose rates of change. We can then say that, generally,
improving the RMSE improves the P-EGA, and, improving
the dRMSE improves the R-EGA.
The CG-EGA is the most important metric as it determines
if a predictive model is safe to use by diabetic people. While
being very self-explanatory (in its simplified representation),
it is a very complex metric. This implies that humans can have
a hard time comparing models solely using the CG-EGA as
the models might have different strengths and weaknesses. In
the other hand, the RMSE and the dRMSE, being single value
metrics, are very simple. This makes the comparison between
models fast and straightforward.
F. Results
The results of our study are represented by Table I. In this
table, the performances of the models, in terms of RMSE
(in mg2/dL2), dRMSE (in mg2/dL2/s), and CG-EGA (in
percentage of predictions falling into the different categories),
are given.
The difference between DCP 1 and DCP 2 relies on the loss
function they use: DCP 1 uses the traditional MSE and DCP
2 uses the MSEDB.
IV. DISCUSSION
A. DCP Results Analysis
First, with higher AP rates, all the fusion models show a
better clinical acceptability than the base predictors. This show
the overall usefulness of using model fusion algorithms in
general. With the EP rates remaining stable, the improvements
come mainly from a shift of BE to AP. Among the fusion
models, the improvements are much more significant for the
DCP models with 10.53% (DCP 1) and 11.54% (DCP 2)
more AP, demonstrating the superiority of the proposed fusion
algorithm.
This improvement is made possible by the increased accu-
racy in the predicted variations represented by the dRMSE.
Nonetheless, we can notice a loss in the prediction accuracy
(RMSE). This is an acceptable trade-off since the prediction
TABLE I: Performances of the models with mean ± standard deviation across the children population.
Models RMSE dRMSE
CG-EGA
Accurate Benign Erroneous
Predictions Errors Predictions
GP 48.47 ± 10.02 5.12 ± 1.14 68.31 ± 7.13 19.94 ± 4.88 11.75 ± 3.40
ELM 42.30 ± 7.13 8.76 ± 1.33 73.62 ± 3.45 20.32 ± 2.11 6.05 ± 1.86
FFNN 37.79 ± 6.11 7.64 ± 0.79 73.99 ± 3.14 21.06 ± 1.99 4.95 ± 1.80
ACP 36.14 ± 6.48 3.50 ± 0.92 78.10 ± 3.74 16.83 ± 2.38 5.07 ± 1.77
AWA 37.51 ± 6.35 5.29 ± 0.71 76.92 ± 2.79 17.61 ± 1.61 5.46 ± 1.50
DCP 1 52.68 ± 7.65 1.32 ± 0.28 84.52 ± 3.40 7.55 ± 2.11 7.93 ± 1.70
DCP 2 49.37 ± 8.61 1.33 ± 0.29 85.53 ± 4.43 7.54 ± 2.50 6.94 ± 2.55
accuracy remains good enough not to threaten the life of the
patient (the clinical acceptability being high).
Figure 3 and 4, taken from a particular day of one of the
patients, illustrate those dynamics. In a first hand, the P-EGA
(representing the accuracy of the predictions) of the DCP
2 model is slighly worse than the one of the ACP model.
But, in the other hand, the R-EGA of the ACP model is
considerably worse than the one of the DCP 2 model, the
predicted variations of the ACP model being more spread out
from the optimal diagonal line.
B. Influence of the MSEDB loss function
Finally, DCP 2, with a lower RMSE and a higher clinical
acceptability when compared to DCP 1, shows the importance
of using the MSEDB loss function. The right side of Figure
3 depicts its influence on the training of the dModel: the
predicted values are closer to the true values because the model
reacts faster to the changes of glucose variations.
V. CONCLUSION
In this work, we proposed a new fusion algorithm, the
Derivatives Combination Predictor, that, by predicting future
glucose values through the prediction of its variations, im-
proves the clinical acceptability of long-term glucose predic-
tions.
To enhance the accuracy of the predictions, we introduced
a new loss function, the MSEDB, specifically designed for the
DCP algorithm.
As a conclusion, the DCP fusion algorithm seems to be
promising at addressing the problem of long-term glucose
predictions. In future studies, we aim to investigate the use
of other models inside the dModel module of the DCP as
well as the use of the algorithm itself inside an end-to-end
glucose predictive model.
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Fig. 4: P/R-EGA of the ACP (a), and DCP 2 (b) models for a child during a specific day. Every prediction is assigned a mark from A to E
in both grids depending on the ground truth. Then, based on both marks, the prediction is said to be an Accurate Prediction (AP, in green),
a Benign Error (BE, in orange), or a Erroneous Prediction (EP, in red).
